Mergers (M&A)

Stevan’s accomplishments include 17 years as a Director in the Vodafone Group. Stevan spent 11 of these years establishing enterprise businesses in the USA and across emerging markets in regions such as Africa, Middle East, India, Asia.

Currently, I leverage my extensive knowledge and network in the biotechnology sector as a Non-Executive Director and Advisor M&A at Pivotal Scientific, a leading biotechnology consultancy that helps companies grow sales and brand awareness. I support the business at all stages of the life cycle, from product development to market entry, and provide guidance on mergers and acquisitions, commercialization, and innovation. I also serve as a board advisor for several biotechnology companies, including 2BScientific, Absolute Antibody, and Trak Global Group, where I contribute to their strategic vision, growth plans, and operational excellence.

Gaby started working in the marketing team at Pivotal in April 2022. Her love of life science started in biology class at school. She went on to study Biomedical Science at Cardiff University and then spent 2 years at the University of Barcelona studying a master’s degree in Translational Medicine where she wrote her thesis on improving the outcome of partial liver transplants.

The role at Pivotal allows Gaby to follow her interest in digital marketing (social media, website design) while still using her science background.

With over 20 years of commercial experience in the life science sector and a PhD in Molecular Genetics from the University of East Anglia, Sian brings a wealth of scientific and industry knowledge to Pivotal Scientific. Prior to PSL, Sian worked predominantly as a product and commercial manager with a focus on identification and analysis of cutting-edge technology, applications and novel scientific companies. Her skillset focused on bringing these technologies to new markets and working to build diverse, integrated portfolios for platforms.  Sian’s experience, combined with her scientific knowledge, places her well to work within our Mergers & Acquisitions team on strategic, buy and sell side projects.

Tim created Pivotal Scientific in 2008 in response to a gap in the market for a company to offer advice and support for small to medium-sized companies in the research reagents sector.

Tim has been involved in the life science industry for over 38 years. He has purchased and sold businesses and created and expanded them from inception to eventual sale. (Serotec Ltd, for whom Tim was Managing Director, sold in 2006, Innova Bioscience where Tim was Chairman sold in June 2017, Nordic-Mubio & Everest Biotech in 2019 and more recently Abcore in 2021).

Tim brings market knowledge and know-how on how to make a research company successful.